GR880100854A - Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος. - Google Patents

Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος.

Info

Publication number
GR880100854A
GR880100854A GR880100854A GR880100854A GR880100854A GR 880100854 A GR880100854 A GR 880100854A GR 880100854 A GR880100854 A GR 880100854A GR 880100854 A GR880100854 A GR 880100854A GR 880100854 A GR880100854 A GR 880100854A
Authority
GR
Greece
Prior art keywords
piperidinylcyclopenthylheptenoic
acid derivative
formulations containing
aqueous formulations
aqueous
Prior art date
Application number
GR880100854A
Other languages
Greek (el)
English (en)
Inventor
Harry Finch
John Anthony Phillips
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878729823A external-priority patent/GB8729823D0/en
Priority claimed from GB888804422A external-priority patent/GB8804422D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GR880100854A publication Critical patent/GR880100854A/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR880100854A 1987-12-22 1988-12-21 Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος. GR880100854A (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878729823A GB8729823D0 (en) 1987-12-22 1987-12-22 Complexes
GB888804422A GB8804422D0 (en) 1988-02-25 1988-02-25 Complexes

Publications (1)

Publication Number Publication Date
GR880100854A true GR880100854A (el) 1994-03-31

Family

ID=26293226

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100854A GR880100854A (el) 1987-12-22 1988-12-21 Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος.

Country Status (29)

Country Link
JP (1) JPH02210A (fr)
KR (1) KR890009402A (fr)
CN (1) CN1034132A (fr)
AT (1) AT395943B (fr)
AU (1) AU615245B2 (fr)
BE (1) BE1001704A3 (fr)
CA (1) CA1328078C (fr)
CH (1) CH676665A5 (fr)
DE (1) DE3843059A1 (fr)
DK (1) DK712888A (fr)
ES (1) ES2011727A6 (fr)
FI (1) FI885920A (fr)
FR (1) FR2624731B1 (fr)
GB (1) GB2211737B (fr)
GR (1) GR880100854A (fr)
HU (1) HU204700B (fr)
IE (1) IE61995B1 (fr)
IL (1) IL88764A0 (fr)
IT (1) IT1224835B (fr)
LU (1) LU87411A1 (fr)
MY (1) MY103952A (fr)
NL (1) NL8803126A (fr)
NO (1) NO885689L (fr)
NZ (1) NZ227446A (fr)
PH (1) PH24982A (fr)
PL (1) PL276595A1 (fr)
PT (1) PT89301B (fr)
SE (1) SE502288C2 (fr)
ZW (1) ZW18088A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814725D0 (en) * 1988-06-21 1988-07-27 Glaxo Group Ltd Medicaments
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
IT1269578B (it) * 1994-04-22 1997-04-08 Chiesi Farma Spa Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
KR100825736B1 (ko) * 2005-12-07 2008-04-29 한국전자통신연구원 무선 xml 전자 서명 서비스 제공 장치 및 그 방법
KR100832740B1 (ko) * 2007-01-17 2008-05-27 한국과학기술원 분지쇄 아미노산 생성능이 개선된 변이 미생물 및 이를이용한 분지쇄 아미노산의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2128674A1 (de) * 1970-06-10 1971-12-16 Ono Pharmaceutical Co. Ltd., Osaka (Japan) Clathratverbindungen
JPS4926416A (fr) * 1972-07-05 1974-03-08
GB2127406A (en) * 1982-09-16 1984-04-11 Glaxo Group Ltd Piperidinylcyclopentanolheptenoic acid salt
WO1986004504A1 (fr) * 1985-02-04 1986-08-14 Schering Aktiengesellschaft Clathrates de 9-halogene prostaglandine et leur utilisation comme medicaments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS57183772A (en) * 1981-04-29 1982-11-12 Glaxo Group Ltd Aminocyclopentanol acids and esters, manufacture and medicinal composition
JPS58116423A (ja) * 1981-12-28 1983-07-11 Sumitomo Chem Co Ltd メタノプロスタサイクリン製剤組成物
JPS58192821A (ja) * 1982-04-30 1983-11-10 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患の治療剤
JPS5946228A (ja) * 1982-09-08 1984-03-15 Zeria Shinyaku Kogyo Kk 生物学的に活性な有機化合物の水溶性及びリンパ移行性薬剤の製造方法
JPS5973576A (ja) * 1982-09-16 1984-04-25 グラクソ・グル−プ・リミテツド ピペリジニルシクロペンタノ−ルヘプテン酸塩
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
JPS60150039A (ja) * 1984-01-17 1985-08-07 Minolta Camera Co Ltd 水陸両用固定焦点カメラ
JPS6327440A (ja) * 1986-07-18 1988-02-05 Sanraku Inc グルコシル化分岐シクロデキストリン含有組成物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2128674A1 (de) * 1970-06-10 1971-12-16 Ono Pharmaceutical Co. Ltd., Osaka (Japan) Clathratverbindungen
JPS4926416A (fr) * 1972-07-05 1974-03-08
GB2127406A (en) * 1982-09-16 1984-04-11 Glaxo Group Ltd Piperidinylcyclopentanolheptenoic acid salt
WO1986004504A1 (fr) * 1985-02-04 1986-08-14 Schering Aktiengesellschaft Clathrates de 9-halogene prostaglandine et leur utilisation comme medicaments

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 81, no. 10, 9th September 1974, page 324, abstract no. 54460r, Columbus, Ohio, US; & JP-A-74 26 416 (ONO PHARMACEUTICAL CO., LTD) 08-03-1974 *
CLAIMS SEARCHED: ALL *
JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 67, no. 12, December 1978, pages 1665-1668, American Pharmaceutical Association, Washington, DC, US; S.G. FRANK et al.: "Phase solubility analysis and PMR study of complexing behavior of dinoprostone with beta-cyclodextrin in water" *

Also Published As

Publication number Publication date
FI885920A (fi) 1989-06-23
NO885689D0 (no) 1988-12-21
FR2624731B1 (fr) 1992-10-23
ES2011727A6 (es) 1990-02-01
PL276595A1 (en) 1989-08-21
BE1001704A3 (fr) 1990-02-13
FR2624731A1 (fr) 1989-06-23
IT1224835B (it) 1990-10-24
SE502288C2 (sv) 1995-09-25
ZW18088A1 (en) 1989-07-26
IE883820L (en) 1989-06-22
NO885689L (no) 1989-06-23
SE8804607D0 (sv) 1988-12-21
AT395943B (de) 1993-04-26
ATA313088A (de) 1992-09-15
CH676665A5 (fr) 1991-02-28
AU2735688A (en) 1989-06-22
IL88764A0 (en) 1989-07-31
PT89301B (pt) 1995-07-03
AU615245B2 (en) 1991-09-26
IE61995B1 (en) 1994-12-14
GB2211737A (en) 1989-07-12
IT8848702A0 (it) 1988-12-21
GB8829793D0 (en) 1989-02-15
NL8803126A (nl) 1989-07-17
NZ227446A (en) 1991-08-27
DK712888A (da) 1989-06-23
PH24982A (en) 1990-12-26
MY103952A (en) 1993-10-30
HU204700B (en) 1992-02-28
JPH02210A (ja) 1990-01-05
KR890009402A (ko) 1989-08-01
HUT50040A (en) 1989-12-28
PT89301A (pt) 1990-06-29
LU87411A1 (fr) 1989-07-07
SE8804607L (sv) 1989-06-23
CN1034132A (zh) 1989-07-26
GB2211737B (en) 1991-12-11
CA1328078C (fr) 1994-03-29
DE3843059A1 (de) 1989-07-13
DK712888D0 (da) 1988-12-21

Similar Documents

Publication Publication Date Title
BR8801158A (pt) Emulsoes aquosas fluorquimicas estaveis
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
DE68925240D1 (de) Phosphinsäure-Derivate
EP0289909A3 (en) All aqueous formulations of organo-phosphorous pesticides
GR880100854A (el) Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος.
DK702688D0 (da) Epipodophyllotoxin-glucosid 4'-acylderivater
DK654888A (da) Farmaceutiske praeprarater indeholdende nedocromilnatrium
MC1960A1 (fr) Derives d'acide hydrocinnamique
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK514188A (da) Acrylsyrederivater
ZA867115B (en) Phosphonic acid derivatives as leather adjuvants
ZA893517B (en) Peptide-drug compositions containing alpha-aminoboronic acid derivatives
DK382688D0 (da) Anti-anxiogeniske sammensaetninger indeholdende dioxopiperidin derivater
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
IT8720227A0 (it) Composizioni antiinfiammatorie-analgesiche contenenti un derivato dell'acido naftil acetico.
PT86621A (pt) Ryfamycin derivative salts
DK650088D0 (da) 5,6,7,8-tetrahydro-4h-isoxazol (4,5-c) azepin-derivater, isomere og syreadditionssalte deraf
IT1217950B (it) Sali di (r,s) 3 (4 fenil 1 piperazinil) 1,2 propandtolo
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.
DK544288D0 (da) 1(2h)-phthalazinoner og terapeutiske praeparater indeholdende saadanne cytoprotektive forbindelser
IT1219733B (it) Derivato dell' acido ursodesossicolico
SE8703671D0 (sv) Blixtlaskondomer "natural choice"
KR880014974U (ko) 트랙터의 카플라(Coupler)
ATA117287A (de) Frontmähwerk
SE8703230D0 (sv) Rock'n-roll